[C:1]([C:4]1[CH:5]=[CH:6][C:7]([OH:13])=[C:8]([CH:12]=1)[C:9]([NH2:11])=[O:10])(=[O:3])[CH3:2].[OH:14][C:15]1[CH:16]=[C:17]([CH:22]=[CH:23][CH:24]=1)[C:18](OC)=O.[NH3:25]>>[C:1]([C:4]1[CH:5]=[CH:6][C:7]([O:13][CH2:2][CH2:1][CH2:4][CH:5]([O:14][C:15]2[CH:24]=[CH:23][CH:22]=[C:17]3[C:16]=2[N:25]=[C:9]([NH2:11])[CH:8]=[CH:18]3)[CH3:6])=[C:8]([CH:12]=1)[C:9]([NH2:11])=[O:10])(=[O:3])[CH3:2]The title compound was prepared according to the procedure described in Example 92 substituting 5-acetyl-2-hydroxybenzamide for methyl 3-hydroxybenzoate. 1H NMR (500 MHz, CDCl3) δ ppm 8.66 (d, 1H), 8.06 (dd, 1H), 7.96 (d, 1H), 7.32 (t, 1H), 7.22 (m, 1H), 7.12 (d, 1H), 7.04 (d, 1H), 6.97 (d, 1H), 4.71 (m, 1H), 4.38 (m, 1H), 4.26 (m, 1H), 2.58 (s, 3H), 2.24 (m, 2H), 1.92–2.13 (m, 2H), 1.48 (d, 3H); MS (DCI/NH3) m/z 408 [M+H]+.